Page last updated: 2024-08-07 13:21:28
Tyrosine-protein kinase Blk
A tyrosine-protein kinase BLK that is encoded in the genome of human. [PRO:DNx, UniProtKB:P51451]
Synonyms
EC 2.7.10.2;
B lymphocyte kinase;
p55-Blk
Research
Bioassay Publications (25)
Timeframe | Studies on this Protein(%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (28.00) | 29.6817 |
2010's | 14 (56.00) | 24.3611 |
2020's | 4 (16.00) | 2.80 |
Compounds (84)
Drugs with Inhibition Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
---|---|---|---|---|---|
pd168393 | Homo sapiens (human) | IC50 | 7.7350 | 2 | 2 |
imatinib | Homo sapiens (human) | GI50 | 7.0500 | 2 | 2 |
staurosporine | Homo sapiens (human) | IC50 | 0.0011 | 2 | 2 |
canertinib | Homo sapiens (human) | IC50 | 0.0395 | 2 | 2 |
birb 796 | Homo sapiens (human) | IC50 | 15.5000 | 2 | 2 |
s 1033 | Homo sapiens (human) | GI50 | 1.3000 | 1 | 1 |
dasatinib | Homo sapiens (human) | GI50 | 0.0050 | 1 | 1 |
sulfuretin | Homo sapiens (human) | IC50 | 2.8800 | 1 | 1 |
a 419259 | Homo sapiens (human) | IC50 | 0.2080 | 1 | 2 |
tofacitinib | Homo sapiens (human) | IC50 | 0.0815 | 1 | 8 |
amg 458 | Homo sapiens (human) | IC50 | 0.5190 | 1 | 1 |
bms 777607 | Homo sapiens (human) | IC50 | 0.5000 | 1 | 1 |
pci 32765 | Homo sapiens (human) | IC50 | 0.0004 | 7 | 7 |
acp-196 | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
bmx-in-1 | Homo sapiens (human) | IC50 | 0.3770 | 1 | 1 |
9-(1-methyl-4-pyrazolyl)-1-[1-(1-oxoprop-2-enyl)-2,3-dihydroindol-6-yl]-2-benzo[h][1,6]naphthyridinone | Homo sapiens (human) | IC50 | 0.3660 | 1 | 1 |
Drugs with Activation Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
---|---|---|---|---|---|
sb 202190 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
imatinib | Homo sapiens (human) | Kd | 0.5200 | 2 | 2 |
staurosporine | Homo sapiens (human) | Kd | 0.0150 | 2 | 2 |
gefitinib | Homo sapiens (human) | Kd | 1.2000 | 2 | 2 |
lestaurtinib | Homo sapiens (human) | Kd | 0.1600 | 2 | 2 |
vatalanib | Homo sapiens (human) | Kd | 10.0000 | 2 | 2 |
ruboxistaurin | Homo sapiens (human) | Kd | 10.0000 | 2 | 2 |
canertinib | Homo sapiens (human) | Kd | 0.0450 | 2 | 2 |
birb 796 | Homo sapiens (human) | Kd | 0.6800 | 2 | 2 |
cyc 202 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
sb 203580 | Homo sapiens (human) | Kd | 10.0000 | 2 | 2 |
enzastaurin | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
erlotinib | Homo sapiens (human) | Kd | 0.1900 | 2 | 2 |
lapatinib | Homo sapiens (human) | Kd | 10.0000 | 2 | 2 |
sorafenib | Homo sapiens (human) | Kd | 10.0000 | 3 | 3 |
pd 173955 | Homo sapiens (human) | Kd | 0.0015 | 1 | 1 |
s 1033 | Homo sapiens (human) | Kd | 0.5000 | 1 | 1 |
bms 387032 | Homo sapiens (human) | Kd | 10.0000 | 2 | 2 |
tandutinib | Homo sapiens (human) | Kd | 10.0000 | 3 | 3 |
vx-745 | Homo sapiens (human) | Kd | 3.1000 | 2 | 2 |
dasatinib | Homo sapiens (human) | Kd | 0.0002 | 2 | 2 |
zd 6474 | Homo sapiens (human) | Kd | 0.0660 | 2 | 2 |
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
alvocidib | Homo sapiens (human) | Kd | 10.0000 | 2 | 2 |
bosutinib | Homo sapiens (human) | Kd | 0.0033 | 1 | 1 |
su 11248 | Homo sapiens (human) | Kd | 0.0650 | 3 | 3 |
jnj-7706621 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
vx680 | Homo sapiens (human) | Kd | 2.2000 | 2 | 2 |
ekb 569 | Homo sapiens (human) | Kd | 0.0780 | 1 | 1 |
axitinib | Homo sapiens (human) | Kd | 3.1000 | 1 | 1 |
pd 184352 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
bms345541 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
midostaurin | Homo sapiens (human) | Kd | 0.5000 | 3 | 3 |
ki 20227 | Homo sapiens (human) | Kd | 0.1200 | 1 | 1 |
cp 724714 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
pi103 | Homo sapiens (human) | Kd | 10.0000 | 2 | 2 |
hki 272 | Homo sapiens (human) | Kd | 0.0850 | 1 | 1 |
tofacitinib | Homo sapiens (human) | Kd | 10.0000 | 2 | 2 |
n-(6-chloro-7-methoxy-9h-beta-carbolin-8-yl)-2-methylnicotinamide | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
cediranib | Homo sapiens (human) | Kd | 0.1200 | 1 | 1 |
masitinib | Homo sapiens (human) | Kd | 0.1500 | 1 | 1 |
pazopanib | Homo sapiens (human) | Kd | 2.6000 | 2 | 2 |
azd 6244 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
su 14813 | Homo sapiens (human) | Kd | 0.7500 | 2 | 2 |
bibw 2992 | Homo sapiens (human) | Kd | 0.2200 | 1 | 1 |
tg100-115 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
pha 665752 | Homo sapiens (human) | Kd | 1.9000 | 1 | 1 |
6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one | Homo sapiens (human) | Kd | 0.0250 | 1 | 1 |
brivanib | Homo sapiens (human) | Kd | 2.0000 | 1 | 1 |
at 7519 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
bi 2536 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
nvp-ast487 | Homo sapiens (human) | Kd | 0.0300 | 2 | 2 |
kw 2449 | Homo sapiens (human) | Kd | 3.5000 | 1 | 1 |
abt 869 | Homo sapiens (human) | Kd | 10.0000 | 2 | 2 |
gw 2580 | Homo sapiens (human) | Kd | 10.0000 | 2 | 2 |
crizotinib | Homo sapiens (human) | Kd | 0.1100 | 1 | 1 |
chir-265 | Homo sapiens (human) | Kd | 8.9500 | 2 | 2 |
motesanib | Homo sapiens (human) | Kd | 2.2000 | 2 | 2 |
mln8054 | Homo sapiens (human) | Kd | 0.0680 | 3 | 3 |
GDC-0879 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
gsk 461364 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
azd 1152-hqpa | Homo sapiens (human) | Kd | 1.5000 | 2 | 2 |
nvp-tae684 | Homo sapiens (human) | Kd | 0.1300 | 1 | 1 |
fedratinib | Homo sapiens (human) | Kd | 0.6500 | 1 | 1 |
gsk690693 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
gdc 0941 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
plx 4720 | Homo sapiens (human) | Kd | 1.1000 | 1 | 1 |
sgx 523 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
pci 32765 | Homo sapiens (human) | Kd | 0.0006 | 1 | 1 |
quizartinib | Homo sapiens (human) | Kd | 10.0000 | 2 | 2 |
incb-018424 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
gsk 1838705a | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
gsk 1363089 | Homo sapiens (human) | Kd | 0.0054 | 1 | 1 |
acp-196 | Homo sapiens (human) | Kd | 0.0180 | 1 | 1 |
chir 258 | Homo sapiens (human) | Kd | 0.1900 | 2 | 2 |
nintedanib | Homo sapiens (human) | Kd | 0.3800 | 1 | 1 |
pp242 | Homo sapiens (human) | Kd | 0.2400 | 1 | 1 |
Enables
This protein enables 5 target(s):
Target | Category | Definition |
---|---|---|
protein tyrosine kinase activity | molecular function | Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate. [RHEA:10596] |
non-membrane spanning protein tyrosine kinase activity | molecular function | Catalysis of the reaction: ATP + protein L-tyrosine = ADP + protein L-tyrosine phosphate by a non-membrane spanning protein. [EC:2.7.10.2] |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
ATP binding | molecular function | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. [ISBN:0198506732] |
signaling receptor binding | molecular function | Binding to one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. [GOC:bf, GOC:ceb, ISBN:0198506732] |
Located In
This protein is located in 1 target(s):
Target | Category | Definition |
---|---|---|
cytosol | cellular component | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. [GOC:hjd, GOC:jl] |
Active In
This protein is active in 1 target(s):
Target | Category | Definition |
---|---|---|
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
Involved In
This protein is involved in 9 target(s):
Target | Category | Definition |
---|---|---|
peptidyl-tyrosine phosphorylation | biological process | The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine. [RESID:AA0039] |
positive regulation of insulin secretion | biological process | Any process that activates or increases the frequency, rate or extent of the regulated release of insulin. [GOC:mah] |
positive regulation of protein binding | biological process | Any process that activates or increases the frequency, rate or extent of protein binding. [GOC:mah] |
intracellular signal transduction | biological process | The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. [GOC:bf, GOC:jl, GOC:signaling, ISBN:3527303782] |
B cell receptor signaling pathway | biological process | The series of molecular signals initiated by the cross-linking of an antigen receptor on a B cell. [GOC:add] |
innate immune response | biological process | Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. [GO_REF:0000022, GOC:add, GOC:ebc, GOC:mtg_sensu] |
protein phosphorylation | biological process | The process of introducing a phosphate group on to a protein. [GOC:hb] |
cell differentiation | biological process | The cellular developmental process in which a relatively unspecialized cell, e.g. embryonic or regenerative cell, acquires specialized structural and/or functional features that characterize a specific cell. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state. [ISBN:0198506732] |
cell surface receptor protein tyrosine kinase signaling pathway | biological process | The series of molecular signals initiated by an extracellular ligand binding to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity, and ending with the regulation of a downstream cellular process, e.g. transcription. [GOC:ceb, GOC:signaling] |